Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Key Points: Compared with intermediate-dose prophylaxis (3 × 1000 IU/wk), high-dose prophylaxis (3 × 2000 IU/wk) resulted in a 66% higher total cost. At age 24 years, high-dose prophylaxis resulted in a small reduction in bleeding and hemophilic arthropathy, but equal quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
Manco-Johnson, M. J., Abshire, T. C., Shapiro, A. D., Riske, B., Hacker, M. R., Kilcoyne, R., Ingram, J. D., Manco-Johnson, M. L., Funk, S., Jacobson, L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067659 · Cited by 1,950 · cited 1×
“At this time, prophylactic dosing is mostly based on the Swedish regimen of 25 to 40 IU/kg per infusion, and dosages used in pediatric trials have been consistently high, at 25 IU/kg thrice weekly or every other day (ie, 3900 and 4550 IU/kg per year, respectively).(6,7) For older patients, guidelines on dosing are una…”
BackgroundSwedish population health-related quality of life results using the EQ-5D
Burström, K., Johannesson, M., & Diderichsen, F. (2001) · Quality of Life Research · doi:10.1023/a:1013171831202 · Cited by 664
Cited by
Oldenburg, J. (2015) · Blood · doi:10.1182/blood-2015-01-528414 · Cited by 376
Berntorp, E., Fischer, K., Hart, D. P., Mancuso, M. E., Stephensen, D., Shapiro, A. D., & Blanchette, V. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00278-x · Cited by 328
Self-citationAdherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study
Schrijvers, L. H., Beijlevelt ‐ van der Zande, M., Peters, M., Lock, J., Cnossen, M. H., Schuurmans, M. J., & Fischer, K. (2016) · British Journal of Haematology · doi:10.1111/bjh.14072 · Cited by 64
Self-citation
Metadata
- Authors
- Fischer, K., Steen Carlsson, K., Petrini, P., Holmström, M., Ljung, R., van den Berg, H. M., & Berntorp, E.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2013-08-15
- Volume
- 122
- Issue
- 7
- Pages
- 1129-1136
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2076845477
- Cited by
- 220
- References
- 5
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. https://app.cochat.ai/papers/10.1182/blood-2012-12-470898
- The paper
- Fischer, K., Steen Carlsson, K., Petrini, P., Holmström, M., Ljung, R., van den Berg, H. M., & Berntorp, E. (2013). Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. Blood. https://doi.org/10.1182/blood-2012-12-470898
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.